2 min read
Veristat aspires to make a difference, every day!
As the weather gets colder and we find ourselves in the holiday season, the employees of Veristat decided to make a difference by helping others in their local communities.
2 min read
Kathleen Boruchowski, Associate Director of Data Management, attended the Medidata NEXTconference in New York City on November 8-10. The conference, which has...
2 min read
Last week, Veristat gathered nearly 200 team members from multiple countries for our annual International Company Meeting. What better a place to host our team meeting than Gillette Stadium,...
2 min read
If you heard the phrase, “You have cancer,” what would be your response?
2 min read
Veristat’s Senior Director of Corporate Compliance attended the 8th Clinical Quality Oversight Forum, an annual conference which took place 10-13 October 2017 in Philadelphia, PA.
2 min read
In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy.
2 min read
Reflecting on the ESMO 2017 Congress that took place in Madrid on 8-12 September, there was a certain frisson of excitement and anticipation around the...
1 min read
Veristat clinical trial project teams help our clients reach their clinical trial milestones and achieve success every day.
1 min read
Veristat has completed the validation and configuration of Master Control’s eTMF system, which is now implemented and available for Veristat managed clinical trials.
1 min read
Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.